Amylyx Pharmaceuticals, Inc. AMLX Proceeds From Exercise Of Stock Options And Restricted Stock Units Vesting
Proceeds From Exercise Of Stock Options And Restricted Stock Units Vesting at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amlx:ProceedsFromExerciseOfStockOptionsAndRestrictedStockUnitsVesting.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s proceeds from exercise of stock options and restricted stock units vesting.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s proceeds from exercise of stock options and restricted stock units vesting?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported proceeds from exercise of stock options and restricted stock units vesting of $7.16M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s proceeds from exercise of stock options and restricted stock units vesting changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s proceeds from exercise of stock options and restricted stock units vesting increased by 638.0% year-over-year, from $970K to $7.16M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s proceeds from exercise of stock options and restricted stock units vesting?
- Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s proceeds from exercise of stock options and restricted stock units vesting has grown at a -23.7% compound annual growth rate (CAGR), from $6.99M to $4.08M.
- What does proceeds from exercise of stock options and restricted stock units vesting mean?
- This represents the cash inflows received by the company when employees or directors exercise vested stock options or when restricted stock units vest. It reflects the liquidity generated from equity-based compensation programs. This metric is a key indicator of the dilution impact and the cash contribution from the company's incentive structures.